Isatuximab plus lenalidomide and dexamethasone with bortezomib as a new standard of care for NDMM TI non-frail patients
During a press conference at ESMO 2012 in Vienna, Jola Gore-Booth discusses the importance of putting personalised medicine into perspective.
Isatuximab plus lenalidomide and dexamethasone with bortezomib as a new standard of care for NDMM TI non-frail patients
Legislation – a powerful tool for promoting massive changes
Gaza's cancer patients: Navigating the dual struggle of illness and war
Tackling breast cancer screening in conservative communities
Cooperative training for medical staff in Côte d'Ivoire: The national radiotherapy and medical oncology center project
Post-diagnosis diet, nutrition and cancer prognosis
Cancer in emergencies: What can we do better to protect the most vulnerable?
Ethics-Guided Radiation Therapy (EGRT): A proposal to refine the practice
Transforming cancer care in Africa: The ECHO project